SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-047560
Filing Date
2022-04-20
Accepted
2022-04-20 07:37:14
Documents
15
Period of Report
2022-04-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2213006d1_8k.htm   iXBRL 8-K 31016
2 EXHIBIT 99.1 tm2213006d1_ex99-1.htm EX-99.1 298463
7 GRAPHIC tm2213006d1_ex99-1img001.jpg GRAPHIC 4036
  Complete submission text file 0001104659-22-047560.txt   580813

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA abt-20220420.xsd EX-101.SCH 3380
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abt-20220420_def.xml EX-101.DEF 28560
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abt-20220420_lab.xml EX-101.LAB 37746
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abt-20220420_pre.xml EX-101.PRE 26778
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2213006d1_8k_htm.xml XML 5460
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-02189 | Film No.: 22836334
SIC: 2834 Pharmaceutical Preparations